Browsing "1. College of Medicine (의과대학)" by Author : 3687

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 23 to 82 of 87

This table browses all dspace content
Issue DateTitleJournal Title
2021Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIALSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2020Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study JOURNAL OF CLINICAL MEDICINE
2017Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort studySEMINARS IN ONCOLOGY
2016Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct CancerCHEMOTHERAPY
2023Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic CancerCANCER RESEARCH
2019Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture CANCER MEDICINE
2022Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer CANCERS
2024Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions GUT AND LIVER
2020FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
2021Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2017Generation and genome analysis of patient-derived pancreatic cancer cell line using conditionally reprogrammed cell method Dissertation
2021GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma BMC CANCER
2022Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study BMC CANCER
2021Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2019Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs BMC MEDICAL GENOMICS
2023Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study SCIENTIFIC REPORTS
2022Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study CANCERS
2016Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease.SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2021Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean populationACTA RADIOLOGICA
2023Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping NATURE COMMUNICATIONS
2024Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis GENOME MEDICINE
2019KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective studyHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
2021Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approachesPANCREATOLOGY
2023Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysisSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2021Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis SCIENTIFIC REPORTS
2023Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care YONSEI MEDICAL JOURNAL
2021Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide studyPANCREATOLOGY
2015Multicentric Type 3 Gastric Neuroendocrine Tumors CLINICAL ENDOSCOPY
2019Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021Optimal drainage of anastomosis stricture after living donor liver transplantationSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2016Past, Present, and Future of Gastrointestinal Stents: New Endoscopic Ultrasonography-Guided Metal Stents and Future Developments CLINICAL ENDOSCOPY
2021Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study FRONTIERS IN ONCOLOGY
2019Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal AdenocarcinomaPANCREAS
2023Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis ADVANCED SCIENCE
2018Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.GASTROINTESTINAL ENDOSCOPY
2014Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigensJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancerEBIOMEDICINE
2022Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer CANCERS
2021Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapyABDOMINAL RADIOLOGY
2016Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses PLOS ONE
2020Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?PANCREATOLOGY
2024Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction AMERICAN JOURNAL OF GASTROENTEROLOGY
2022Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection SCIENTIFIC REPORTS
2023ResponseGASTROINTESTINAL ENDOSCOPY
2022Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis GUT AND LIVER
2022Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9RADIOLOGY
2018Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstructionHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
2022Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial CANCERS
2021Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma CANCERS
2020Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2019Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX ChemotherapyNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2016Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients MEDICINE
2016Systemic Chemotherapy in Advanced Pancreatic Cancer GUT AND LIVER
2017The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancerJOURNAL OF MOLECULAR RECOGNITION
2023The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer GUT AND LIVER
2017The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic CancerNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2024Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer BMC CANCER
2015Trends in receiving chemotherapy for advanced cancer patients at the end of life BMC PALLIATIVE CARE
12

Browse

Links